Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6320-6328

  Armengol, Maria Pilar ^a   Cardoso Schmidt, Cristina B ^a   Fernández, Marco ^b   Ferrer, Xavier ^a   Pujol Borrell, Ricardo ^a,b   Juan, Manel ^a  

^a Ctr Transfusion and Tissue Bank   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE LIGAND 12; CHEMOKINE LIGAND 13; CHEMOKINE LIGAND 22; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; LIGAND; LYMPHOTOXIN; LYMPHOTOXIN BETA; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH FOLLICLE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0037942750     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6320     Document Type: Article

References (43)

1. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
2. Viret, C., K. A. Barlow, and C. A. Janeway, Jr. 1999. On the intrathymic intercellular transfer of self-determinants. Immunol. Today 20:8.
3. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301.
4. Zinkernagel, R. M., E. S. Aichele, S. Oehen, T. Kundig, and H. Hengartner. 1997. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:199.
5. Pulendran, B., R. van Driel, and G. J. Nossal. 1997. Immunological tolerance in germinal centres. Immunol. Today 18:27.
6. Han, S., B. Zheng, J. Dal Porto, and G. Kelsoe. 1995. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J. Exp. Med. 182:1635.
7. Hjelmstrom, P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukocyte Biol. 69:331.
8. Murakami, J., Y. Shimizu, Y. Kashii, T. Kato, M. Minemura, K. Okada, S. Nambu, T. Takahara, K. Higuchi, Y. Maeda, T. Kumada, and A. Watanabe. 1999. Functional B cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 30:143.
9. Zaitoun, A. M. 1995. The prevalence of lymphoid follicles in Helicobacter pylori associated gastritis in patients with ulcers and non-ulcer dyspepsia. J. Clin. Pathol. 48:325.
10. Crawford, D. H., and S. M. McLachlan. 1983. The relationship between the Epstein-Barr virus and rheumatoid arthritis. Br. J. Rheumatol. 22:129.
11. Schröder, A. E., A. Greiner, C. Seyfert, and C. Berek. 1996. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93:221.
12. Itoh, K., E. Meffre, E. Albesiano, A. Farber, D. Dines, P. Stein, S. E. Asnis, R. A. Furie, R. I. Jain, and N. Chiorazzi. 2000. Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J. Exp. Med. 192:1151.
13. Shione, H., Y. Fujii, M. Okumura, Y. Yakeuchi, M. Inoue, and H. Matsuda. 1997. Failure to down-regulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis. Eur. J. Immunol. 27:805.
14. Sims, G. P., H. Shiono, N. Willcox, and D. I. Stott. 2001. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167:1935.
15. Stott, D., F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek. 1998. Antigen-driven clonal proliferation of B cell within the target tissue of an autoimmune disease. J. Clin. Invest. 102:938.
16. Wallace, W. E. H., S. E. M. Howie, and A. S. Krajewaki. 1996. The immunological architecture of B-lymphocytes aggregates in cryptogenic fibrosing alveolitis. J. Pathol. 178:323.
17. Ruddle, N. H. 1999. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development. Immunol. Res. 19:119.
18. Weetman, A. P., and A. M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15:788.
19. Armengol, M. P., M. Juan, A. Lucas-Martín, M. T. Fernández-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borrell. 2001. Ectopic lymphoid follicles in thyroid autoimmune glands are sites of active B cell expansion and maturation: relevance to pathogenesis. Am. J. Pathol. 159:861.
20. McLachlan, S. M., G. Proud, C. A. Pegg, F. Clark, and B. Rees Smith. 1985. Functional analysis of T and B cells from blood and thyroid tissue in Hashimoto's disease. Clin. Exp. Immunol. 59:585.
21. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12:336.
22. Tanabe, S., Z. Lu, Y. Luo, E. J. Quackenbush, M. A. Berman, L. A. Collins-Racie, S. Mi, C. Reilly, D. Lo, K. A. Jacobs, and M. E. Dorf. 1997. Identification of a new mouse β-chemokine, TCA4, with activity on T-lymphocytes and mesangial cells. J. Immunol. 159:5671.
23. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, and A. Mantovani. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595.
24. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aluti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal-cell derived-factor 1 (SDF-1). J. Exp. Med. 184:1001.
25. Gunn, M., V. N. N'go, K. M. Ansel, E. H. Ekland, G. C. Jason, and L. T. Williams. 1998. A B cell homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799.
26. Ashhab, Y., O. Domínguez, M. Sospedra, C. Roura Mir, A. Lucas-Martín, and R. Pujol-Borrell. 1999. A one-tube polymerase chain reaction protocol demonstrates CC-chemokine overexpression in Graves' disease glands. J. Clin. Endocr. Metab. 84:2873.
27. Kokkotou, E., P. Marafelia, E. I. Mantzos, and N. A. Tritos. 2002. Serum monocyte chemoattractant protein-I is increased in chronic autoimmune thyroiditis. Metabolism 51:1489.
28. Aust, G., D. Sittig, M. Steinert, P. Lamesch, and T. Lohmann T. 2002. Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin. Exp. Immunol. 127:479.
29. Gouldvestre, C., F. Batteux, and J. Charreire. 2002. Chemokines modulate experimental autoimmune thyroiditis through attraction of autoreactive or regulatory T cells. Eur. J. Immunol. 32:3435.
30. Pujol-Borrell, R., L Todd, M. Londei, A. Foulis, M. Feldmann, and G. F. Bottazzo. 1986. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic β cells in type I diabetes. Mol. Biol. Med. 3:159.
31. Belflore, A., T. Mauerhoff, R. Pujol-Borrell, K. Badenhoop, M. Buscema, R. Mirakian, and G. F. Bottazzo. 1991. De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells. J. Autoimmun. 4:397.
32. Monstein, H. J., A. G. Nylander, and D. Chen. 1995. RNA extraction from gastrointestinal tract and pancreas by a modified Chomczynski and Sacchi method. BioTechniques 19:340.
33. Poznansky, M. C., I. T. Olszak, R. Foxall, R. H. Evans, A. D. Luster, and D. T. Scadden. 2000. Active movement of T cells away from a chemokine. Nat. Med. 6:543.
34. Sospedra, M., X. Ferrer-Francesch, O. Domínguez, M. Juan, M. Foz-Sala, and R. Pujol-Borrell. 1998. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol. 161:5918.
35. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive lymphocytes. Proc. Natl. Acad. Sci. USA 95:258.
36. Christopherson, K. W., 2nd, A. F. Hood, J. B. Travers, H. Ramsey, and R. A. Hromas. 2003. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoinimune diseases. Blood 101:801.
37. Grant, A. J., S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D. G. Jackson, M. Briskin, L. Wu, S. G. Hubscher, and D. H. Adams. 2002. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am. J. Pathol. 160:1445.
38. Xanthou, G., M. Polihronis, A. G. Tzioufas, S. Paikos, P. Sideras, and H. M. Moutsopoulos. 2001. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 44:208.
39. Kasai, K., N. Banba, S. Motohashi, Y. Hattori, K. Manaka, and S. I. Shimoda. 1996. Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes. FEBS Lett. 394:137.
40. + lymphocytes. J. Clin. Endocr. Metab. 88:508.
41. Romagnani, P., M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, A. Bellastella, and M. Serio. 2002. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am. J. Pathol. 161:195.
42. + T cells are required for iodine accelerated thyroiditis in NOD mice. Cell. Immunol. 192:113.
43. Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, and M. Feldmann. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115.